Table 3.
Genes showing significant changes between the COPD group and the exposure control group by microarray analysis.
| Gene name | Average fold change∗ | SD | P value |
|---|---|---|---|
| ESD | 5.04 | 1.68 | 2.79E-02 |
| PRKRIR | 4.60 | 1.67 | 1.90E-03 |
| RAB3IP | 3.62 | 1.68 | 3.50E-03 |
| ARHGAP26 | 3.35 | 1.85 | 1.41E-02 |
| CBR3 | 3.23 | 1.79 | 4.80E-02 |
| MEIS1 | 3.17 | 1.79 | 1.09E-02 |
| CEMP1 | 3.08 | 1.87 | 8.00E-04 |
| TTC13 | 3.08 | 1.80 | 1.25E-02 |
| EDEM3 | 2.95 | 1.80 | 2.71E-02 |
| ZNF737 | 2.90 | 1.80 | 2.10E-06 |
| PCDH15 | 2.90 | 1.79 | 6.65E-04 |
| CARD8 | 2.90 | 1.79 | 5.36E-03 |
| ZNF799 | 2.87 | 1.85 | 4.91E-02 |
| SLC35F4 | 2.82 | 1.85 | 1.41E-02 |
| C8orf48 | 2.77 | 1.85 | 4.47E-02 |
| TMTC2 | 2.68 | 1.84 | 1.65E-02 |
| NPR3 | 2.68 | 1.84 | 1.04E-02 |
| LAMA1 | 2.63 | 1.89 | 1.47E-02 |
| FBXW2 | 2.62 | 1.89 | 7.30E-03 |
| BCKDHB | 2.62 | 1.89 | 9.00E-03 |
| SYNE1 | 2.59 | 2.04 | 4.71E-02 |
| SPEF2 | 2.56 | 2.32 | 2.37E-02 |
| COL15A1 | 2.52 | 2.08 | 2.10E-02 |
| CDK17 | 2.51 | 2.10 | 6.06E-03 |
| ZNF461 | 0.45 | 3.43 | 7.22E-03 |
| TFEC | 0.45 | 3.45 | 3.68E-02 |
| NTNG1 | 0.45 | 3.49 | 7.70E-03 |
| ZNF789 | 0.45 | 3.53 | 1.38E-02 |
| FAM83G | 0.45 | 3.55 | 1.36E-02 |
| SCNM1 | 0.44 | 3.25 | 4.41E-02 |
| TP53I11 | 0.44 | 3.07 | 2.38E-02 |
| TMEM63A | 0.43 | 2.95 | 8.30E-03 |
| AOC3 | 0.43 | 2.96 | 2.78E-02 |
| HAND2 | 0.42 | 1.97 | 8.06E-03 |
| ZCCHC16 | 0.42 | 1.90 | 8.40E-03 |
| B3GNT4 | 0.41 | 2.05 | 1.10E-02 |
| FBXO25 | 0.37 | 2.12 | 1.80E-03 |
| C1orf220 | 0.35 | 2.32 | 1.13E-02 |
| OFD1 | 0.24 | 3.83 | 1.37E-02 |
∗Compared with the exposed control group.